Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsy.
Herrmann
J
J
Mall
V
V
Bigalke
H
H
Geth
K
K
Korinthenberg
R
R
Heinen
F
F
D000293:Adolescent; D000917:Antibody Formation; D019274:Botulinum Toxins, Type A / Q000276:immunology* / Q000494:pharmacology*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D009465:Neuromuscular Agents / Q000276:immunology* / Q000494:pharmacology*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A